Business
BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair
BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair
About this update from Genmab A/s
[{"type":"text","content":"MENLO PARK, Calif., Dec. 9, 2025 /PRNewswire/ – BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the appointment of Anthony Pagano to its Board of Directors, effective January 1, 2026. Mr. Pagano will also serve as Chair of the Audit Committee.","length":375,"tagName":"p"},{"type":"image","alt":"BillionToOne logo (PRNewsfoto/BillionToOne)","displaySize":"","headline":null,"caption":"BillionToOne logo (PRNewsfoto/BillionToOne)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":121,"url":"https://media.zenfs.com/en/prnewswire.com/20c9d4f2a4e11a8715e2cb466cbe9442"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/KXnIRmSRXCDdDYiP3GJB2g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIxMztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/20c9d4f2a4e11a8715e2cb466cbe9442","width":400,"height":121}},"href":"https://mma.prnewswire.com/media/1855547/Billion_To_One_Logo_New.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Mr. Pagano is currently Chief Financial Officer and Executive Vice President of Genmab, a leading international biotechnology company, a position he has held since March 2020. He joined Genmab in December 2007, establishing a strong track record of driving financial performance and strategic growth throughout his tenure. During Mr. Pagano's tenure, Genmab has grown from $100M in annual revenues to more than $3B, developing, launching and commercializing differentiated and innovative antibody therapeutics that improve the lives of patients.","length":549,"tagName":"p"},{"type":"text","content":"Before his role at Genmab, Mr. Pagano served as Corporate Controller and Senior Director of Business Planning for NovaDel Pharma, a publicly traded specialty pharma company. He started his professional career at KPMG LLP, where he advanced to Manager and provided audit and mergers & acquisitions consulting services to a diverse client base spanning startups to Fortune 500 corporations across multiple industries.","length":419,"tagName":"p"},{"type":"text","content":"Mr. Pagano is a Certified Public Accountant and holds a B.S. in Accounting from The College of New Jersey and an M.B.A. from the Stern School of Business at New York University.","leng...